Respiratorius
1.65 SEK
-4.35 %
Less than 1K followers
RESP
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-4.35 %
+1.85 %
-6.25 %
-33.47 %
-77.34 %
-75.74 %
-96.90 %
-99.10 %
-88.47 %
Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was established in 1999 as a spin-off from Lund University. The operations are located in Sweden, where research is conducted in-house, but also through international partners. The company has its headquarters in Lund.
Read moreMarket cap
13.04M SEK
Turnover
27.44K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
10/2
2026
Annual report '25
All
Press releases
ShowingAll content types
Respiratorius: Delårsrapport 3, 2025
Sista dag för handel med BTA i Respiratorius
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools